142816-70-4

Basic information

• Product Name: 4-N-benzoylgeMcitabine
• Synonyms: 4-N-benzoylgeMcitabine;N-Benzoyl-2'-deoxy-2',2'-difluorocytidine
• CAS NO: 142816-70-4
• Molecular Formula: C₁₆H₁₅F₂N₃O₅
• Molecular Weight: 367.3042064
• Mol File: 142816-70-4.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-N-benzoylgeMcitabine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-N-benzoylgeMcitabine(142816-70-4)
• EPA Substance Registry System: 4-N-benzoylgeMcitabine(142816-70-4)

Safety Data

• Hazardous Substances Data: 142816-70-4(Hazardous Substances Data)

Upstream product

• 98-88-4 benzoyl chloride 
• 122111-03-9 gemcitabine hydrochloride 
• 95058-81-4 gemcitabine 

Downstream Products

• 95058-81-4 gemcitabine 
• 1145869-48-2 1-(4-N-benzoyl-2',5'-dideoxy-2',2'-difluoro-β-D-pent-4-enoribofuranosyl)cytosine 
• 1365255-30-6 C₁₆H₁₃F₂IN₆O₄ 
• 142808-44-4 5'-O-(4,4'-dimethoxytrityl)-3'-O-(2-cyanoethyl-N,N'-diisopropylphosphoramidite)-N⁴-benzoyl-2'-deoxy-2',2'-difluorocytidine 
• 1145869-47-1 1-(4-N-benzoyl-2'-dideoxy-2',2'-difluoro-5'-iodo-β-D-ribofuranosyl)cytosine 
• 608122-30-1 N-benzoyl-5'-O-(tert-butyldimethylsilyl)-2'-deoxy-2',2'-difluorocytidine 
• 608122-33-4 (N-benzoyl-2'-deoxy-2',2'-difluoro-3-acetyl-5'-monophosphate-1-dodecylthio-2-decyloxypropyl)cytidine 
• 608122-31-2 N-benzoyl-5'-O-(tert-butyldimethylsilyl)-2'-deoxy-2',2'-difluoro-3-acetylcytidine 
• 608122-32-3 N-benzoyl-2'-deoxy-2',2'-difluoro-3-acetylcytidine 

Relevant articles and documents

Oligomer-nucleoside phosphate conjugates

The invention provides small molecule drugs that are chemically modified by covalent attachment of a water soluble, non-peptidic oligomer. The conjugates of the invention, when administered by any of a number administration routes, exhibits advantages ove

COMPOSITION CONTAINING MODIFIED DERIVATIVES OF A CYTIDINE ANTIMETABOLITE FOR THE TREATMENT OF SUSCEPTIBLE DISEASE

The present invention relates to homo-oligomeric derivatives of a cytidine antimetabolite and its use for the treatment of susceptible diseases. The cytidine antimetabolite is preferably a compound made of 2-20 units of dFdC linked with 5' - 3' phosphate

Novel oligonucleotides and related compounds

The present invention relates generally to oligonucleotides and more specifically to oligonucleotides which have a sequence including at least two CDG dinucleotides and a prodrug of an antimetabolite. The prodrug can be part of a CpG dinucleotide or may be attached elsewhere on the oligonucleotide.